Eureka Therapeutics Expands Scientific Advisory Board with Appointment of Industry Leaders Dr. Hideho Okada and Dr. Nai-Kong Cheung
April 20, 2017 08:00 AM Eastern Daylight Time EMERYVILLE, Calif. -Eureka Therapeutics, Inc., a biotechnology company focused on developing novel T-cell immunotherapies for the treatment